| Revenues | | 11,489.00 | 12,502.00 | 12,222.00 | 12,269.00 |
| Cost Of Revenue | | 3,421.00 | 4,097.00 | 3,435.00 | 3,372.00 |
| | 1,617.00 | - | - | - |
| Selling, General, and Administrative | | 1,617.00 | - | - | - |
| Research and Development | | 2,649.00 | - | - | - |
| Costs And Expenses | | 8,250.00 | 11,032.00 | 9,108.00 | 10,496.00 |
| Income/Loss From Equity Method Investments | | 25.00 | 100.00 | -6.00 | -37.00 |
| Income/Loss From Continuing Operations Before Tax | | 3,240.00 | 1,470.00 | 3,114.00 | 1,773.00 |
| Income Tax Expense/Benefit, Deferred | | 161.00 | -392.00 | -359.00 | -437.00 |
| Income Tax Expense/Benefit | | 561.00 | 384.00 | 919.00 | 460.00 |
| | 2,678.00 | 1,085.00 | 2,195.00 | 1,313.00 |
| Attributable To Parent | | 2,677.00 | 1,087.00 | 2,201.00 | 1,310.00 |
| Basic Average Shares | | 2,038.00 | - | 2,036.00 | 2,035.00 |
| Diluted Average Shares | | 2,047.00 | - | 2,039.00 | 2,038.00 |
| Basic Earnings Per Share | | 1.31 | 0.54 | 1.08 | 0.64 |
| Diluted Earnings Per Share | | 1.31 | 0.53 | 1.08 | 0.64 |
| Common Stock Dividends | 0.63 | 0.63 | - | 0.62 | 0.62 |
BMY
